Loss-of-function mutations cause persistent and unregulated insulin secretion and congenital hyperinsulinism [2–4], whereas gain-of-function mutations prevent KATP channel closure in response to glucose metabolism, resulting in a failure of insulin secretion and neonatal diabetes [5, 6]. This evidence concerns the gene INS and hyperinsulinism.